Patrys
Manufacturing · Australia · 1-10 Employees
View Company Info for Free
Overview
Headquarters
L 4 100 Albert Rd, South Melbourne, Vict...Phone Number
(973) 714-6611Website
www.patrys.comRevenue
<$5 MillionStock Symbol
PABIndustry
About Patrys
Patrys Org Chart
Is Patrys your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Patrys, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Patrys is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Patrys has new funding data
Click to see if Patrys had a recent Job posting/layoffs
Earning: See what the market has to say on Patrys recently announced quarterly report
Check if Patrys has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Patrys launches new products
Congratulate Masked Content for being promoted to Masked Content at Patrys
Recommended Actions
Reach out to Masked Content who joined Patrys as Masked Content
Find 2 more new buyers
Compare Similar Companies to Patrys
Compare insights from companies similar to Patrys, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Patrys is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Patrys is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Patrys.
Patrys Tech Stack
A closer look at the technologies used by Patrys
Most Recent Scoops
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Patrys
Patrys Limited is a publicly-listed company dedicated to developing innovative antibody technologies aimed at treating hard-to-treat cancers and addressing acute delirium. The company is advancing a proprietary IV formulation of quetiapine for delirium, targeting patients in postoperative, intensive care, and palliative care settings. Additionally,... Read More